Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation in the Emergency Department: A Randomized Placebo-Controlled Trial

To see complete record on, please visit this link

Id: NCT05217706

Organisation Name: Rady Children's Hospital, San Diego

Overal Status: Recruiting

Start Date: March 1, 2022

Last Update: March 21, 2022

Lead Sponsor: Rady Children's Hospital, San Diego

Brief Summary: The goal of this study is to test whether a single low-dose of IV ketamine given in the emergency department to adolescents with treatment-resistant depression and suicidal ideation can reduce depression symptoms and suicidal thoughts compared to placebo. Participants will complete depression scales at baseline, and 1 hour, 3 hours, 1 day, 3 days, and 7 days after receiving the treatment.

  • Depression
  • Suicidal Ideation

Total execution time in seconds: 3.9472968578339